If I understand correctly, your argument is "shareholders should be happy to be ripped off by a Director because a Director wouldn't bother to arrange juicy free and totally unearned options for himself (by grabbing them from the members of the consortium which approached ILA) if he thought the drug wasn't safe and effective"?
IMO that's a pathetic argument.
It means that:
* shareholders should be resigned to being ripped off by Directors
* shareholders are incapable of looking at preclinical and clinical evidence for themselves and must rely entirely on watching what Directors do.
My apologies if I've misunderstood your argument..
Hold, Held
Ann: Letter to Shareholders, Notice of AGM & Proxy Form, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.015(11.1%) |
Mkt cap ! $35.41M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 15.5¢ | 13.0¢ | $58.96K | 402.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11332 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 42405 | 4 |
View Market Depth
| Last trade - 16.15pm 26/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |